Impact Analysis of Covid-19
The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.
Computational biology focuses on the development and application of data-analytical and theoretical methods, mathematical modeling and computational simulation techniques in life sciences.
The global computational biology market is estimated to account for US$ 12,601.1 Mn in terms of value by the end of 2027.
Global Computational Biology Market: Drivers
High cost of drug development is expected to propel growth of the global computational biology market over the forecast period. For instance, according to an analysis published in JAMA in March 2020, U.S. biopharmaceutical companies spent around US$ 1 billion to bring each of their new drugs to market between 2009 and 2018.
Moreover, several benefits of computational biology are also expected to aid in growth of the market. Predictive modeling tools in computational biology can provide invaluable information to better streamline drug development process. Predictive modelling helps to reduce the total number of recruited patients and to shorten the duration of clinical trials.
North America held dominant position in the global computational biology market in 2019, accounting for 44.2% share in terms of value, followed by Europe and Asia Pacific, respectively
Figure 1: Global Computational Biology Market Share (%) Value, By Region, 2019
Global Computational Biology Market: Restraints
Enormous data with lack of standardization has limited the growth of computational biology market. There is rise in need for combination of the available software to build a composite application for current single task tools. The tools should be compatible with each other and should be able to use the same data effectively. User friendly databases are needed to reduce the time and effort currently being spent on the analysis of petabytes of data available with institutions and governments across the world.
Moreover, issues with data storage and organization are also limiting growth of the market. Rapid data accumulation poses challenges in organizing the data as it is diverse and may belong to populations, disease associations, symptoms, therapeutic drugs, and others.
Computational Biology Market Report Coverage
||Market Size in 2019:
||US$ 3,453.2 Mn
|Historical Data for:
||2016 to 2019
||2020 to 2027
|Forecast Period 2020 to 2027 CAGR:
||2027 Value Projection:
||US$ 12,601.1 Mn
|Geographies covered (27):
- North America: U.S., Canada
- Latin America: Brazil, Argentina, Mexico, Rest of Latin America
- Europe: Germany, U.K., France, Spain, Italy, Russia, Rest of Europe
- Asia Pacific: China, Japan, India, Australia, South Korea, ASEAN, Rest of Asia Pacific
- Middle East: GCC Countries, Israel, Rest of Middle East
- Africa: North Africa, Central Africa, South Africa
- By Type
- Cellular & Biological Simulation: Computational Genomics, Computational Proteomics, Pharmacogenomics, Others (Transcriptomics/Metabolomic).
- Disease Modeling and Simulation Applications: Drug Discovery, Drug Development.
- By Tools: Content/Database, Analysis Software & Services, IT Infrastructure (Hardware).
Accelrys, Certara, L.P., Chemical Computing Group Inc., Compugen, Ltd., Entelos, Inc. (Rosa & Co. LLC), Genedata AG, Insilico Biotechnology AG, Leadscope, Inc., Nimbus Discovery LLC, Rhenovia Pharma SAS, Schrodinger, and Simulation Plus, Inc.
- Increasing prevalence of chronic disorders
|Restraints & Challenges:
- High Cost of Infrastructure
Global Computational Biology Market: Opportunities
Developing computer networks for surveillance of disease and mapping the pathways and biological networks associated with the initiation is expected to offer lucrative growth opportunities for players in the global computational biology market.
Moreover, increasing prevalence of chronic disorders is also expected to aid in growth of the market. For instance, according to the American Cancer Society, in 2019, there will be an estimated 1,762,450 new cancer cases diagnosed and 606,880 cancer deaths in the U.S.
The global computational biology market was valued at US$ 3,453.2 Mn in 2019 and is forecast to reach a value of US$ 12,601.1 Mn by 2027 at a CAGR of 17.6% between 2020 and 2027.
Figure 2: Global Computational Biology Market Value (US$ Mn), 2016 – 2027
Market Trends/Key Takeaways
Increasing focus on reducing cost of drug development has led to manufacturers to adopt 3D modeling systems to analyze samples. Use of 3D modeling systems aids in recording rare cell events, accurate cell counts, improved sensitivity of detection, thereby accelerating the drug discovery process.
Major players in the market are focused on launching products and services that aid in treatment and management of Covid-19. For instance, in April 2020, Certara L.P. launched the COVID-19 Pharmacology Resource Center to help advance therapeutics for COVID-19.
Global Computational Biology Market: Competitive Landscape
Major players operating in the global computational biology market include, Accelrys, Certara, L.P., Chemical Computing Group Inc., Compugen, Ltd., Entelos, Inc. (Rosa & Co. LLC), Genedata AG, Insilico Biotechnology AG, Leadscope, Inc., Nimbus Discovery LLC, Rhenovia Pharma SAS, Schrodinger, and Simulation Plus, Inc.
Global Computational Biology Market: Key Developments
Major players in the market are focused on launching new products to expand their product portfolio. For instance, in May 2020, Genedata, AG launched Genedata Imagence 2.0, the latest version of its enterprise software for high-content screening (HCS) image analysis.
Major players in the market are also focused on adopting collaboration strategies to enhance their market share. For instance, in March 2019, Rosa & Co. LLC collaborated with Chugai Pharmaceutical Co., Ltd. Under the collaboration Rosa & Co. LLC will provide its PhysioPD research services for R&D in multiple therapeutic areas.